The Environmental Protection Agency today released a list of commercial medical device sterilizing facilities where lifetime risk from ethylene oxide emissions are highest to people who live nearby. In addition, the Food and Drug Administration released a statement highlighting how the agency is working to reduce ethylene oxide use and support innovation in medical device sterilization, while underscoring its concern about potential shortages that could result from disruptions in sterilizer operations. About half of medical devices are sterilized using ethylene oxide. The EPA will host an Aug. 10 webinar to update and hear from stakeholders as it prepares to propose an air pollution regulation next year to address ethylene oxide emissions. Register here to attend.

Related News Articles

Headline
The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U…
Headline
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…